TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.

Faye M Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.